Mast cells differentially express and release active high molecular weight neurotrophins

被引:84
作者
Skaper, SD [1 ]
Pollock, M [1 ]
Facci, L [1 ]
机构
[1] GlaxoSmithKline, Neurol Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England
来源
MOLECULAR BRAIN RESEARCH | 2001年 / 97卷 / 02期
关键词
mast cell; nerve growth factor; neurotrophin-3; neurotrophin-4; sensory neuron; inflammation;
D O I
10.1016/S0169-328X(01)00314-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Nerve growth factor (NGF), a target-derived factor for survival and maintenance of peripheral and central neurons, has been implicated in inflammatory processes. Mast cells are the principal effector cells in IgE-dependent hypersensitivity reactions, and also play a role in diseases characterised by inflammation, including those of the nervous system like multiple sclerosis. Mast cells are capable of synthesising and responding to NGF, although the occurrence of other members of the NGF family of neurotrophins and their protein forms have not been described. Immunoblot analysis with highly selective neurotrophin antibodies has now been used to show that rat peritoneal mast cells express a higher molecular weight form (73 kDa) of NGF, but not the monomeric (13 kDa) NGF polypeptide. Mast cells also expressed 73 kDa forms of neurotrophin-4 and neurotrophin-3; brain-derived neurotrophic factor was not detected. Medium conditioned by degranulating peritoneal mast cells contained similar high molecular weight forms of NGF and neurotrophin-4 on Western blots, but no neurotrophin-3. Mast cell-derived neurotrophin immunoreactivities were inhibited by the respective peptide antigen, further demonstrating the specificity of the mast cell-derived neurotrophic protein. Mast cell-released proteins supported the survival of cultured chicken embryonic neural crest- and placode-derived sensory neurons; neurotrophic activities were inhibited by neutralising antibodies for NGF and neurotrophin-4, respectively. High molecular isoforms of neurotrophins have been reported to occur in experimental colitis and in the inflamed gut of patients with Crohn's disease and ulcerative colitis, tissue sites rich-in mast cells. The data suggest an important role for neurotrophins in the pathophysiology of inflammatory disease. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:177 / 185
页数:9
相关论文
共 48 条
  • [31] Reinshagen M., 1996, Society for Neuroscience Abstracts, V22, P298
  • [32] Reinshagen M, 1997, GASTROENTEROLOGY, V112, pA1070
  • [33] Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo
    Rozniecki, JJ
    Dimitriadou, V
    Lambracht-Hall, M
    Pang, XZ
    Theoharides, TC
    [J]. BRAIN RESEARCH, 1999, 849 (1-2) : 1 - 15
  • [34] Nerve growth factor expression and release in allergic inflammatory disease of the upper airways
    Sanico, AM
    Stanisz, AM
    Gleeson, TD
    Bora, S
    Proud, D
    Bienenstock, J
    Koliatsos, VE
    Togias, A
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (05) : 1631 - 1635
  • [35] Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways
    Sawada, J
    Itakura, A
    Tanaka, A
    Furusaka, T
    Matsuda, H
    [J]. BLOOD, 2000, 95 (06) : 2052 - 2058
  • [36] NGF - NOT JUST FOR NEURONS
    SCULLY, JL
    OTTEN, U
    [J]. CELL BIOLOGY INTERNATIONAL, 1995, 19 (05) : 459 - 469
  • [37] Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases
    Seidah, NG
    Benjannet, S
    Pareek, S
    Savaria, D
    Hamelin, J
    Goulet, B
    Laliberte, J
    Lazure, C
    Chretien, M
    Murphy, RA
    [J]. BIOCHEMICAL JOURNAL, 1996, 314 : 951 - 960
  • [38] Mast cells in the brain: Evidence and functional significance
    Silver, R
    Silverman, AJ
    Vitkovic, L
    Lederhendler, II
    [J]. TRENDS IN NEUROSCIENCES, 1996, 19 (01) : 25 - 31
  • [39] Simone MD, 1999, HEMATOL ONCOL, V17, P1
  • [40] SKAPER SD, 1990, METHODS NEUROSCIENCE, V2, P17